Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AMGN | VRTX | REGN | GSK |
| Company | Bristol-Myers Squibb Company | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 43.56 | 309.53 | 419.00 | 959.59 | 44.30 |
| High | 44.81 | 314.60 | 420.63 | 969.98 | 44.72 |
| Low | 43.49 | 306.32 | 416.03 | 956.76 | 44.30 |
| Last | 44.74 | 312.86 | 418.99 | 968.00 | 44.67 |
| Change | +1.07 | +5.55 | +0.17 | +12.24 | +0.53 |
| % Change | +2.45% | +1.81% | +0.04% | +1.28% | +1.20% |
| Volume | 10,622,069 | 2,920,454 | 676,001 | 274,621 | 2,938,906 |
| 20-Day Average Volume | 14,348,450 | 2,906,839 | 1,114,565 | 507,091 | 3,290,670 |
| Previous Close | 43.67 | 307.31 | 418.82 | 955.76 | 44.14 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.17 | 279.47 | 400.63 | 915.54 | 41.67 |
| 20-Day Raw Stochastic | 22.60% | 84.27% | 80.77% | 96.01% | 99.10% |
| 20-Day Relative Strength | 35.71% | 68.03% | 60.08% | 60.06% | 69.57% |
| Weighted Alpha | -34.69 | +35.65 | +21.42 | +30.41 | +28.50 |
| Today's Opinion | 100% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 48% Sell | 40% Sell | 24% Buy | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.38% since 05/02/24 | +12.38% since 05/02/24 | +4.71% since 05/02/24 | +3.24% since 05/02/24 | +3.04% since 05/02/24 |
| Low | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 394.03 on 05/07/24 | 926.94 on 05/03/24 | 43.17 on 05/06/24 |
| High | 44.81 on 05/09/24 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 971.86 on 05/08/24 | 44.72 on 05/09/24 |
| 1-Month | |||||
| %Chg | -13.29% since 04/09/24 | +15.72% since 04/09/24 | +3.59% since 04/09/24 | +2.55% since 04/09/24 | +9.27% since 04/09/24 |
| Low | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 971.86 on 05/08/24 | 44.72 on 05/09/24 |
| 3-Month | |||||
| %Chg | -10.18% since 02/09/24 | +7.47% since 02/09/24 | -0.93% since 02/09/24 | +1.53% since 02/09/24 | +6.59% since 02/09/24 |
| Low | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 44.72 on 05/09/24 |
| 6-Month | |||||
| %Chg | -11.25% since 11/09/23 | +18.48% since 11/09/23 | +13.68% since 11/09/23 | +20.96% since 11/09/23 | +29.63% since 11/09/23 |
| Low | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 33.89 on 11/10/23 |
| High | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 44.72 on 05/09/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 88,523,448 | 164,851,840 | 108,247,808 | 104,906,128 | 91,477,504 |
| Shares Outstanding, K | 2,027,100 | 536,435 | 258,459 | 109,762 | 2,072,440 |
| Annual Sales | 45,006,000,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | 8,025,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 11,865,000,000 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -11,911,000,000 | -113,000,000 | 968,800,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.45 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.40 on 04/25/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | N/A | 0.397 on 02/22/24 |
| Next Ex-Dividends Date | 04/04/24 | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 41.94 | 16.12 | 27.24 | 26.14 | 10.93 |